Sanofi announced the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration and innovation with the ultimate goal of bringing medicines and vaccines to patients faster.
New Jersey Governor Phil Murphy and Morristown officials were expected to attend the ribbon-cutting ceremony along with Sanofi CEO Paul Hudson and other senior company officials. The Morristown offices are the latest step in the delivery of Sanofi's science-driven, best-in-class workplace portfolio worldwide, notably an expansive corporate hub and R&D center in Cambridge, Massachusetts, which opened in 2022. The New Jersey opening - an investment of $130 million - further strengthens Sanofi's presence in the United States.
The new offices bring together nearly 2,000 employees across disciplines in a new 260,000-square-foot facility that features flexible workspaces, digitally enabled smart design, and best-in-class amenities, including wellness rooms, a restaurant open to the public, and the largest outdoor terrace space in New Jersey. Employees enjoy light-filled workspaces that utilize natural materials, largely sourced locally, as well as tactile finishes with contributions from local artists.
Sanofi's Morristown offices will be US Green Building Council LEED® Gold Certified and compliant with WELL Gold Building standards, incorporating sophisticated design elements that align with Sanofi's commitment to protect people, the planet, and the community. Employees will benefit from sustainable features such as fully subsidized and easily accessible public transportation, including Wi-Fi-enabled shuttles, and electric vehicle chargers on site. The building is designed to use approximately 28% less energy and reduce greenhouse gas emissions by over 24% compared to standard office spaces, while reducing water use by 37% through efficient fixtures and thoughtful design.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!